Equities research analysts at StockNews.com initiated coverage on shares of 22nd Century Group (NASDAQ:XXII – Get Free Report) in a research report issued on Friday. The firm set a “sell” rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
Shares of XXII opened at $0.10 on Friday. The stock has a market capitalization of $859,051.20, a price-to-earnings ratio of 0.00 and a beta of 1.39. The firm has a fifty day simple moving average of $0.24 and a 200 day simple moving average of $0.74. 22nd Century Group has a 12 month low of $0.09 and a 12 month high of $8.63.
22nd Century Group (NASDAQ:XXII – Get Free Report) last released its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.36) earnings per share for the quarter. 22nd Century Group had a negative net margin of 275.12% and a negative return on equity of 380.39%. The firm had revenue of $7.95 million during the quarter.
Institutional Investors Weigh In On 22nd Century Group
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Read More
- Five stocks we like better than 22nd Century Group
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- How to Use Stock Screeners to Find Stocks
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- How to Invest in the FAANG Stocks
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.